BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 17446544)

  • 21. Sirolimus-eluting stents to abolish intimal hyperplasia and improve flow in porcine arteriovenous grafts: a 4-week follow-up study.
    Rotmans JI; Pattynama PM; Verhagen HJ; Hino I; Velema E; Pasterkamp G; Stroes ES
    Circulation; 2005 Mar; 111(12):1537-42. PubMed ID: 15781738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human placental ectonucleoside triphosphate diphosphohydrolase gene transfer via gelatin-coated stents prevents in-stent thrombosis.
    Takemoto Y; Kawata H; Soeda T; Imagawa K; Somekawa S; Takeda Y; Uemura S; Matsumoto M; Fujimura Y; Jo J; Kimura Y; Tabata Y; Saito Y
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):857-62. PubMed ID: 19325141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of nonporous PTFE-covered stents on intimal hyperplasia following balloon arterial injury in minipigs.
    Yuan JG; Ohki T; Marin ML; Quintos RT; Krohn DL; Beitler JJ; Veith FJ
    J Endovasc Surg; 1998 Nov; 5(4):349-58. PubMed ID: 9867326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel drug-eluting stent coated with an integrin-binding cyclic Arg-Gly-Asp peptide inhibits neointimal hyperplasia by recruiting endothelial progenitor cells.
    Blindt R; Vogt F; Astafieva I; Fach C; Hristov M; Krott N; Seitz B; Kapurniotu A; Kwok C; Dewor M; Bosserhoff AK; Bernhagen J; Hanrath P; Hoffmann R; Weber C
    J Am Coll Cardiol; 2006 May; 47(9):1786-95. PubMed ID: 16682302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of vascular endothelial growth factor-transfected human endothelial cells on endothelialization and restenosis of stainless steel stents.
    Tang C; Wang G; Wu X; Li Z; Shen Y; Lee JC; Yu Q
    J Vasc Surg; 2011 Feb; 53(2):461-71. PubMed ID: 21129910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonporous silicone polymer coating of expanded polytetrafluoroethylene grafts reduces graft neointimal hyperplasia in dog and baboon models.
    Lumsden AB; Chen C; Coyle KA; Ofenloch JC; Wang JH; Yasuda HK; Hanson SR
    J Vasc Surg; 1996 Nov; 24(5):825-33. PubMed ID: 8918330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Local delivery of anti-monocyte chemoattractant protein-1 by gene-eluting stents attenuates in-stent stenosis in rabbits and monkeys.
    Egashira K; Nakano K; Ohtani K; Funakoshi K; Zhao G; Ihara Y; Koga J; Kimura S; Tominaga R; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2563-8. PubMed ID: 17885211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy of nanoscale poly[bis(trifluoroethoxy) phosphazene] (PTFEP) coatings in reducing thrombogenicity and late in-stent stenosis in a porcine coronary artery model.
    Satzl S; Henn C; Christoph P; Kurz P; Stampfl U; Stampfl S; Thomas F; Radeleff B; Berger I; Grunze M; Richter GM
    Invest Radiol; 2007 May; 42(5):303-11. PubMed ID: 17414526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of a polyphosphazene nanocoat in reducing thrombogenicity, in-stent stenosis, and inflammatory response in porcine renal and iliac artery stents.
    Henn C; Satzl S; Christoph P; Kurz P; Radeleff B; Stampfl U; Stampfl S; Berger I; Richter GM
    J Vasc Interv Radiol; 2008 Mar; 19(3):427-37. PubMed ID: 18295704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
    Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Percutaneous revascularization of persistent renal artery in-stent restenosis.
    Patel PM; Eisenberg J; Islam MA; Maree AO; Rosenfield KA
    Vasc Med; 2009 Aug; 14(3):259-64. PubMed ID: 19651676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma.
    Joner M; Morimoto K; Kasukawa H; Steigerwald K; Merl S; Nakazawa G; John MC; Finn AV; Acampado E; Kolodgie FD; Gold HK; Virmani R
    Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):1960-6. PubMed ID: 18688017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of the secondary deployment of expanded polytetrafluoroethylene-covered stent grafts on maintenance of transjugular intrahepatic portosystemic shunt patency.
    Jirkovsky V; Fejfar T; Safka V; Hulek P; Krajina A; Chovanec V; Raupach J; Lojik M; Vanasek T; Renc O; Ali SM
    J Vasc Interv Radiol; 2011 Jan; 22(1):55-60. PubMed ID: 21106389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healing of PTFE grafts in a pig model recruit neointimal cells from different sources and do not endothelialize.
    Mellander S; Fogelstrand P; Enocson K; Johansson BR; Mattsson E
    Eur J Vasc Endovasc Surg; 2005 Jul; 30(1):63-70. PubMed ID: 15933985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of tissue reaction with three different endografts used for exclusion of carotid artery aneurysm in a dog model.
    Zhu YQ; Cheng YS; Li MH; Zhang HX; Zhao JG; Wang YL
    J Vasc Interv Radiol; 2009 Jun; 20(6):791-8. PubMed ID: 19318281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the deployment and healing of thin-walled expanded PTFE stented grafts and covered stents.
    White R; Kopchok G; Zalewski M; Ayres B; Wilson E; de Virgilio C; Donayre C
    Ann Vasc Surg; 1996 Jul; 10(4):336-46. PubMed ID: 8879388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal dosing and duration of oral everolimus to inhibit in-stent neointimal growth in rabbit iliac arteries.
    Waksman R; Pakala R; Baffour R; Hellinga D; Seabron R; Kolodgie F; Virmani R
    Cardiovasc Revasc Med; 2006; 7(3):179-84. PubMed ID: 16945826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biocompatibility of tetramethylpyrazine-eluting stents in normal porcine coronary arteries.
    Ma GS; Chen LJ; Chen Z; Ding S; Shen CX; Feng Y
    Biomed Pharmacother; 2008 Feb; 62(2):125-9. PubMed ID: 17764890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of covered stents in the central vein: a feasibility study in a canine model.
    Shin BS; Park MH; Jeon GS; Lee BM; Lee K; Kang DY; Kang SG; Han YM
    J Endovasc Ther; 2011 Dec; 18(6):802-10. PubMed ID: 22149230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of a microporous thermoplastic polyurethane-covered stent with a self-expanding bare nitinol stent in a porcine iliac artery model.
    Radeleff B; Grenacher L; Christoph P; Sommer CM; Stampfl U; Ramsauer S; Henn T; Kurz P; Lopez-Benitez R; Berger I; Richter GM
    J Vasc Interv Radiol; 2009 Jul; 20(7):927-35. PubMed ID: 19497761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.